Cargando…

Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study

BACKGROUND: The aim of this study was to compare the risk of developing sudden sensorineural hearing loss (SSHL) in patients with hypopharyngeal cancer with that in patients with nasopharyngeal carcinoma (NPC). METHODS: A population-based, retrospective cohort study was performed using the Taiwan Na...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hung, Tu, Tzong-Yang, Wu, Chuan-Song, Kuo, Ting-Yu, Huang, Chii-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478193/
https://www.ncbi.nlm.nih.gov/pubmed/32221154
http://dx.doi.org/10.1097/JCMA.0000000000000314
_version_ 1783580009165750272
author Chang, Hung
Tu, Tzong-Yang
Wu, Chuan-Song
Kuo, Ting-Yu
Huang, Chii-Yuan
author_facet Chang, Hung
Tu, Tzong-Yang
Wu, Chuan-Song
Kuo, Ting-Yu
Huang, Chii-Yuan
author_sort Chang, Hung
collection PubMed
description BACKGROUND: The aim of this study was to compare the risk of developing sudden sensorineural hearing loss (SSHL) in patients with hypopharyngeal cancer with that in patients with nasopharyngeal carcinoma (NPC). METHODS: A population-based, retrospective cohort study was performed using the Taiwan National Health Research Database databank. Patients selected for this study were diagnosed with hypopharyngeal cancer or NPC and treated with radiotherapy in the period from 2001 to 2004. Routine follow-up was conducted for 8 years (2004–2012), and the incidence of SSHL was calculated at the final follow-up. RESULTS: There was no significant difference in the risk of developing SSHL between the hypopharyngeal cancer group and its control group (p = 1.000). In hypopharyngeal cancer and NPC groups, the rates of SSHL were 0.12% and 1.00%, respectively (p < 0.001). The cumulative hazard of SSHL during the follow-up period was significantly higher in the NPC group than in the control group (p < 0.001). CONCLUSION: Radiotherapy in patients with hypopharyngeal cancer did not increase the risk of developing SSHL, but postirradiation NPC was significantly associated with an increased incidence of SSHL.
format Online
Article
Text
id pubmed-7478193
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74781932020-09-16 Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study Chang, Hung Tu, Tzong-Yang Wu, Chuan-Song Kuo, Ting-Yu Huang, Chii-Yuan J Chin Med Assoc Original Articles BACKGROUND: The aim of this study was to compare the risk of developing sudden sensorineural hearing loss (SSHL) in patients with hypopharyngeal cancer with that in patients with nasopharyngeal carcinoma (NPC). METHODS: A population-based, retrospective cohort study was performed using the Taiwan National Health Research Database databank. Patients selected for this study were diagnosed with hypopharyngeal cancer or NPC and treated with radiotherapy in the period from 2001 to 2004. Routine follow-up was conducted for 8 years (2004–2012), and the incidence of SSHL was calculated at the final follow-up. RESULTS: There was no significant difference in the risk of developing SSHL between the hypopharyngeal cancer group and its control group (p = 1.000). In hypopharyngeal cancer and NPC groups, the rates of SSHL were 0.12% and 1.00%, respectively (p < 0.001). The cumulative hazard of SSHL during the follow-up period was significantly higher in the NPC group than in the control group (p < 0.001). CONCLUSION: Radiotherapy in patients with hypopharyngeal cancer did not increase the risk of developing SSHL, but postirradiation NPC was significantly associated with an increased incidence of SSHL. Lippincott Williams & Wilkins 2020-03-30 2020-09 /pmc/articles/PMC7478193/ /pubmed/32221154 http://dx.doi.org/10.1097/JCMA.0000000000000314 Text en Copyright © 2020, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Articles
Chang, Hung
Tu, Tzong-Yang
Wu, Chuan-Song
Kuo, Ting-Yu
Huang, Chii-Yuan
Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study
title Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study
title_full Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study
title_fullStr Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study
title_full_unstemmed Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study
title_short Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study
title_sort is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? a population-based study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478193/
https://www.ncbi.nlm.nih.gov/pubmed/32221154
http://dx.doi.org/10.1097/JCMA.0000000000000314
work_keys_str_mv AT changhung istheriskofidiopathicsuddensensorineuralhearinglosshigherinnasopharyngealcarcinomathaninhypopharyngealcancerapopulationbasedstudy
AT tutzongyang istheriskofidiopathicsuddensensorineuralhearinglosshigherinnasopharyngealcarcinomathaninhypopharyngealcancerapopulationbasedstudy
AT wuchuansong istheriskofidiopathicsuddensensorineuralhearinglosshigherinnasopharyngealcarcinomathaninhypopharyngealcancerapopulationbasedstudy
AT kuotingyu istheriskofidiopathicsuddensensorineuralhearinglosshigherinnasopharyngealcarcinomathaninhypopharyngealcancerapopulationbasedstudy
AT huangchiiyuan istheriskofidiopathicsuddensensorineuralhearinglosshigherinnasopharyngealcarcinomathaninhypopharyngealcancerapopulationbasedstudy